triamcinolone acetonide has been researched along with latanoprost in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Cheng, YH; Chiou, SH; Chiu, AW; Hung, KH; Ku, RY; Lee, CJ; Liu, CJ; Tsai, TH | 1 |
| Do, A; Ertel, M; Huang, MJ; Larsen, CL; Levin, A; Panarelli, JF; Pantcheva, M; Samuelson, TW; Sheybani, A | 1 |
3 other study(ies) available for triamcinolone acetonide and latanoprost
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Sustained delivery of latanoprost by thermosensitive chitosan-gelatin-based hydrogel for controlling ocular hypertension.
Topics: Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Chitosan; Delayed-Action Preparations; Drug Evaluation, Preclinical; Gelatin; Humans; Hydrogels; Latanoprost; Male; Ocular Hypertension; Prostaglandins F, Synthetic; Rabbits; Triamcinolone Acetonide | 2014 |
Extreme intraocular pressure and steroid-dependent iritis.
Topics: Acetazolamide; Female; Humans; Intraocular Pressure; Iritis; Latanoprost; Loteprednol Etabonate; Middle Aged; Triamcinolone Acetonide | 2023 |